These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 8826565

  • 41. Proposed synergistic effect of calcium channel blockers with lipid-lowering therapy in retarding progression of coronary atherosclerosis.
    Jukema JW, van Boven AJ, Zwinderman AH, Van der Laarse A, Bruschke AV.
    Cardiovasc Drugs Ther; 1998 Apr; 12 Suppl 1():111-8. PubMed ID: 9642484
    [Abstract] [Full Text] [Related]

  • 42. Calcium channel blockers in treatment of hypertension.
    Muntwyler J, Follath F.
    Prog Cardiovasc Dis; 2001 Apr; 44(3):207-16. PubMed ID: 11727278
    [Abstract] [Full Text] [Related]

  • 43. Additive effects of diuretics or sodium restriction with calcium channel blockers in the treatment of hypertension.
    Weinberger MH.
    J Cardiovasc Pharmacol; 1988 Apr; 12 Suppl 4():S72-5. PubMed ID: 2468879
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Efficacy of the combination of amlodipine and candesartan in hypertensive patients with coronary artery disease: a subanalysis of the HIJ-CREATE study.
    Koyanagi R, Hagiwara N, Yamaguchi J, Kawada-Watanabe E, Haruta S, Takagi A, Ogawa H, HIJ-CREATE Investigators.
    J Cardiol; 2013 Oct; 62(4):217-23. PubMed ID: 23778009
    [Abstract] [Full Text] [Related]

  • 46. Calcium-channel blockers and cognitive function in elderly people: results from the Canadian Study of Health and Aging.
    Maxwell CJ, Hogan DB, Ebly EM.
    CMAJ; 1999 Sep 07; 161(5):501-6. PubMed ID: 10497605
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Effect of clopidogrel combined with calcium-channel blocker on coronary artery disease in elderly patients: a propensity score-based retrospective cohort study].
    Gao Y, Lu X, Cao J, Liu X, Ma C, Fan L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr 07; 32(4):462-6. PubMed ID: 22543122
    [Abstract] [Full Text] [Related]

  • 50. Calcium channel blockers in the prevention of end stage renal disease: a review.
    Derwa A, Peeters P, Vanholder R.
    Acta Clin Belg; 2004 Apr 07; 59(1):44-56. PubMed ID: 15065696
    [Abstract] [Full Text] [Related]

  • 51. Clinical trial experience around the globe: focus on calcium-channel blockers.
    White WB.
    Clin Cardiol; 2003 Feb 07; 26(2 Suppl 2):II7-11. PubMed ID: 12622320
    [Abstract] [Full Text] [Related]

  • 52. [Views on the use of calcium channel blockers in the treatment of heart ischemia and hypertension].
    Halawa B.
    Pol Merkur Lekarski; 1998 Sep 07; 5(27):107-10. PubMed ID: 10101470
    [Abstract] [Full Text] [Related]

  • 53. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension.
    Andreadis EA, Tsourous GI, Marakomichelakis GE, Katsanou PM, Fotia ME, Vassilopoulos CV, Diamantopoulos EJ.
    J Hum Hypertens; 2005 Jun 07; 19(6):491-6. PubMed ID: 15759025
    [Abstract] [Full Text] [Related]

  • 54. [Treatment of elderly hypertension with Ca channel blockers].
    Saito F, Kushiro T.
    Clin Calcium; 2005 Oct 07; 15(10):1717-25. PubMed ID: 16199919
    [Abstract] [Full Text] [Related]

  • 55. Combined use of nifedipine and diltiazem for the treatment of severe hypertension.
    Busse JC, de Velasco RE, Pellegrini EL.
    South Med J; 1991 Apr 07; 84(4):502-4. PubMed ID: 2014439
    [Abstract] [Full Text] [Related]

  • 56. Influence of calcium channel blockers in patients with gastrointestinal disease in Japanese community pharmacies.
    Hamada A, Akiyoshi R, Ishii J, Hamada N, Miyazaki C, Hamada T, Ohwaki Y, Ikeda R, Wada M, Nakashima K.
    J Clin Pharm Ther; 2012 Feb 07; 37(1):74-7. PubMed ID: 21395634
    [Abstract] [Full Text] [Related]

  • 57. Combination therapy in hypertension: A focus on angiotensin receptor blockers and calcium channel blockers.
    Meka N, Katragadda S, Cherian B, Arora RR.
    Am J Ther; 2010 Feb 07; 17(1):61-7. PubMed ID: 20090431
    [Abstract] [Full Text] [Related]

  • 58. High-dose insulin therapy for calcium-channel blocker overdose.
    Shepherd G, Klein-Schwartz W.
    Ann Pharmacother; 2005 May 07; 39(5):923-30. PubMed ID: 15811898
    [Abstract] [Full Text] [Related]

  • 59. Efficacy and safety of calcium channel blockers in hypertensive patients with concomitant left ventricular dysfunction.
    Parmley WW.
    Clin Cardiol; 1992 Apr 07; 15(4):235-42. PubMed ID: 1563126
    [Abstract] [Full Text] [Related]

  • 60. Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure.
    Oliveto A, Mancino M, Sanders N, Cargile C, Benjamin Guise J, Bickel W, Brooks Gentry W.
    Eur J Pharmacol; 2013 Sep 05; 715(1-3):424-35. PubMed ID: 23524089
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.